MUC1: a multifaceted oncoprotein with a key role in cancer progression

Hattrup, 2008, Structure and function of the cell surface (tethered) mucins, Annu. Rev. Physiol., 70, 431, 10.1146/annurev.physiol.70.113006.100659 Gendler, 1995, Epithelial mucin genes, Annu. Rev. Physiol., 57, 607, 10.1146/annurev.ph.57.030195.003135 Gendler, 2001, MUC1, the renaissance molecule, J. Mammary Gland Biol. Neoplasia, 6, 339, 10.1023/A:1011379725811 Chang, 2000, The epithelial mucin, MUC1, is expressed on resting T lymphocytes and can function as a negative regulator of T cell activation, Cell. Immunol., 201, 83, 10.1006/cimm.2000.1643 Hanisch, 2000, MUC1: the polymorphic appearance of a human mucin, Glycobiology, 10, 439, 10.1093/glycob/10.5.439 Yolken, 1992, Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis, J. Clin. Invest., 90, 1984, 10.1172/JCI116078 Schroten, 1992, Inhibition of adhesion of S-fimbriated Escherichia coli to buccal epithelial cells by human milk fat globule membrane components: a novel aspect of the protective function of mucins in the nonimmunoglobulin fraction, Infect. Immun., 60, 2893, 10.1128/IAI.60.7.2893-2899.1992 Kufe, 2009, Mucins in cancer: function, prognosis and therapy, Nat. Rev. Cancer, 9, 874, 10.1038/nrc2761 Lau, 2004, Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study, Am. J. Clin. Pathol., 122, 61, 10.1309/9R6673QEC06D86Y4 Levitin, 2005, The MUC1 SEA module is a self-cleaving domain, J. Biol. Chem., 280, 33374, 10.1074/jbc.M506047200 Gendler, 1990, Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin*, J. Biol. Chem., 265, 15286, 10.1016/S0021-9258(18)77254-2 Muller, 1999, High density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells, J. Biol. Chem., 274, 18165, 10.1074/jbc.274.26.18165 Spicer, 1991, Molecular cloning and analysis of the mouse homologue of the tumor-associated mucin, MUC1, reveals conservation of potential O-glycosylation sites, transmembrane, and cytoplasmic domains and a loss of minisatellite-like polymorphism, J. Biol. Chem., 266, 15099, 10.1016/S0021-9258(18)98592-3 Parry, 2006, N-Glycosylation of the MUC1 mucin in epithelial cells and secretions, Glycobiology, 16, 623, 10.1093/glycob/cwj110 Altschuler, 2000, Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state, Mol. Biol. Cell, 11, 819, 10.1091/mbc.11.3.819 Thathiah, 2003, Tumor necrosis factor-α converting enzyme/ADAM 17 mediates MUC1 shedding, J. Biol. Chem., 278, 3386, 10.1074/jbc.M208326200 Thathiah, 2004, MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17, Biochem. J., 382, 363, 10.1042/BJ20040513 Carson, 2008, The cytoplasmic tail of MUC1: a very busy place, Sci. Signal., 1, pe35, 10.1126/scisignal.127pe35 Mahanta, 2008, A minimal fragment of MUC1 mediates growth of cancer cells, PLoS ONE, 3, e2054, 10.1371/journal.pone.0002054 Smagghe, 2013, MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naïve state, PLoS ONE, 8, e58601, 10.1371/journal.pone.0058601 Julian, 2009, MUC1 is a substrate for γ-secretase, J. Cell. Biochem., 108, 802, 10.1002/jcb.22292 Raina, 2012, Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells, Int. J. Oncol., 40, 1643 Kumar, 2012, The MUC1 extracellular domain subunit is found in nuclear speckles and associates with spliceosomes, PLoS ONE, 7, e42712, 10.1371/journal.pone.0042712 Spicer, 1995, Analysis of mammalian MUC1 genes reveals potential functionally important domains, Mamm. Genome, 6, 885, 10.1007/BF00292441 Merlo, 1989, Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas, Cancer Res., 49, 6966 Yamada, 2008, MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells, Cancer Res., 68, 2708, 10.1158/0008-5472.CAN-07-6844 Zaretsky, 1999, Analysis of the promoter of the MUC1 gene overexpressed in breast cancer, FEBS Lett., 461, 189, 10.1016/S0014-5793(99)01452-0 Lagow, 2002, Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon-γ and tumor necrosis factor-α, J. Biol. Chem., 86, 759 Rajabi, 2010, Mucin 1 oncoprotein expression is suppressed by the miR-125b oncomir, Genes Cancer, 1, 62, 10.1177/1947601909357933 Zhang, 2013, Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms, Cancer Immunol. Immunother., 62, 423, 10.1007/s00262-012-1325-2 Obermair, 2001, Novel MUC1 splice variants are expressed in cervical carcinoma, Gynecol. Oncol., 83, 343, 10.1006/gyno.2001.6396 Ligtenberg, 1990, Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini, J. Biol. Chem., 265, 5573, 10.1016/S0021-9258(19)39399-8 Zrihan-Licht, 1994, Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue, Eur. J. Biochem., 224, 787, 10.1111/j.1432-1033.1994.00787.x Oosterkamp, 1997, Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z), Int. J. Cancer, 72, 87, 10.1002/(SICI)1097-0215(19970703)72:1<87::AID-IJC13>3.0.CO;2-7 Schut, 2003, MUC1 expression, splice variant and short form transcription (MUC1/Z, MUC1/Y) in prostate cell lines and tissue, BJU Int., 91, 278, 10.1046/j.1464-410X.2003.03062.x Baruch, 1997, Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function, Int. J. Cancer, 71, 741, 10.1002/(SICI)1097-0215(19970529)71:5<741::AID-IJC9>3.0.CO;2-R Levitin, 2005, A novel protein derived from the MUC1 gene by alternative splicing and frameshifting, J. Biol. Chem., 280, 10655, 10.1074/jbc.M406943200 Baruch, 1999, The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein, Cancer Res., 59, 1552 Whitehouse, 1997, A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans, J. Cell Biol., 137, 1229, 10.1083/jcb.137.6.1229 Brockhausen, 1995, Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells, Eur. J. Biochem., 233, 607, 10.1111/j.1432-1033.1995.607_2.x Picco, 2010, Over-expression of ST3Gal-I promotes mammary tumorigenesis, Glycobiology, 20, 1241, 10.1093/glycob/cwq085 Mann, 1997, Low O-acetylation of sialyl-Lex contributes to its overexpression in colon carcinoma metastases, Int. J. Cancer, 72, 258, 10.1002/(SICI)1097-0215(19970717)72:2<258::AID-IJC10>3.0.CO;2-C Hollingsworth, 2004, Mucins in cancer: protection and control of the cell surface, Nat. Rev. Cancer, 4, 45, 10.1038/nrc1251 Thompson, 2006, Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-κB pathways, Mol. Cancer Res., 4, 489, 10.1158/1541-7786.MCR-06-0038 Nath, 2013, MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes, Oncogenesis, 2, e51, 10.1038/oncsis.2013.16 Li, 1998, Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin, Mol. Cell. Biol., 18, 7216, 10.1128/MCB.18.12.7216 Wei, 2005, Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response, Cancer Cell, 7, 167, 10.1016/j.ccr.2005.01.008 Ahmad, 2009, MUC1-C oncoprotein functions as a direct activator of the nuclear factor-κB p65 transcription factor, Cancer Res., 69, 7013, 10.1158/0008-5472.CAN-09-0523 Ahmad, 2011, MUC1-C oncoprotein promotes STAT3 activation in an auto-inductive regulatory loop, Sci. Signal., 4, ra9, 10.1126/scisignal.2001426 Hattrup, 2006, MUC1 alters oncogenic events and transcription in human breast cancer cells, Breast Cancer Res., 8, R37, 10.1186/bcr1515 Roy, 2011, MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition, Oncogene, 30, 1449, 10.1038/onc.2010.526 Sahraei, 2012, MUC1 regulates PDGFA expression during pancreatic cancer progression, Oncogene, 31, 4935, 10.1038/onc.2011.651 Behrens, 2010, The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF, Oncogene, 29, 5667, 10.1038/onc.2010.327 Cascio, 2011, MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-κB p65 and binding to cytokine promoters: importance of extracellular domain, J. Biol. Chem., 286, 42248, 10.1074/jbc.M111.297630 Rowse, 1995, Delayed mammary tumor progression in Muc-1 null mice, J. Biol. Chem., 270, 30093, 10.1074/jbc.270.50.30093 Besmer, 2011, Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis, Cancer Res., 71, 4432, 10.1158/0008-5472.CAN-10-4439 Tinder, 2008, MUC1 enhances tumor progression and contributes towards immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma, J. Immunol., 181, 3116, 10.4049/jimmunol.181.5.3116 Raina, 2004, The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts, J. Biol. Chem., 279, 20607, 10.1074/jbc.M310538200 Bitler, 2010, MUC1 regulates nuclear localization and function of the epidermal growth factor receptor, J. Cell Sci., 123, 1716, 10.1242/jcs.062661 Chaika, 2012, MUC1 mucin stabilizes and activates hypoxia-inducible factor 1α to regulate metabolism in pancreatic cancer, Proc. Natl. Acad. Sci. U.S.A., 109, 13787, 10.1073/pnas.1203339109 Kalluri, 2009, Review series. The basics of epithelial–mesenchymal transition, J. Clin. Invest., 119, 1420, 10.1172/JCI39104 Singh, 2007, Platelet-derived growth factor receptor β-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells, Cancer Res., 67, 5201, 10.1158/0008-5472.CAN-06-4647 Cascio, 2013, Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration, Oncotarget, 4, 1686, 10.18632/oncotarget.1265 Lüttges, 2002, The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas, Am. J. Surg. Pathol., 26, 466, 10.1097/00000478-200204000-00008 Nakamori, 1994, MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma, Gastroenterology, 106, 353, 10.1016/0016-5085(94)90592-4 Kashiwagi, 2000, DF3 expression in human gallbladder carcinoma: significance for lymphatic invasion, Int. J. Oncol., 16, 455 Hayashi, 2001, MUC1 mucin core protein binds to the domain 1 of ICAM-1, Digestion, 63, 87, 10.1159/000051917 Rodgers, 2000, Sialyl Lewisx-mediated, PSGL-1-independent rolling adhesion on P-selectin, Biophys. J., 79, 694, 10.1016/S0006-3495(00)76328-4 Wesseling, 1995, Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components, J. Cell Biol., 129, 255, 10.1083/jcb.129.1.255 Kitamoto, 2012, MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors, Oncogene, 32, 4614, 10.1038/onc.2012.478 Woo, 2012, Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway, Oncogene, 31, 2187, 10.1038/onc.2011.410 Aubert, 2009, MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression, Cancer Res., 69, 5707, 10.1158/0008-5472.CAN-08-4905 Yin, 2003, Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress, J. Biol. Chem., 278, 35458, 10.1074/jbc.M301987200 Yin, 2007, Mucin 1 oncoprotein blocks hypoxia-inducible factor 1α activation in a survival response to hypoxia, J. Biol. Chem., 282, 257, 10.1074/jbc.M610156200 Persidis, 1999, Cancer multidrug resistance, Nat. Biotechnol., 17, 94, 10.1038/5289 Balkwill, 2001, Inflammation and cancer: back to Virchow?, Lancet, 357, 539, 10.1016/S0140-6736(00)04046-0 Rakoff-Nahoum, 2006, Why cancer and inflammation?, Yale J. Biol. Med., 79, 123 Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205 Sheng, 2013, MUC1 and MUC13 differentially regulate epithelial inflammation in response to inflammatory and infectious stimuli, Mucosal Immunol., 6, 557, 10.1038/mi.2012.98 Choi, 2011, TNF-α is a key regulator of MUC1, an anti-inflammatory molecule, during airway Pseudomonas aeruginosa infection, Am. J. Respir. Cell Mol. Biol., 44, 255, 10.1165/rcmb.2009-0323OC Li, 2010, Anti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro, Am. J. Physiol. Lung Cell. Mol. Physiol., 298, 558, 10.1152/ajplung.00225.2009 Lu, 2013, Cutting edge: enhanced pulmonary clearance of Pseudomonas aeruginosa by Muc1 knockout mice, J. Immunol., 176, 3890, 10.4049/jimmunol.176.7.3890 Ueno, 2008, MUC1 mucin is a negative regulator of Toll-like receptor signaling, Am. J. Respir. Cell Mol. Biol., 38, 263, 10.1165/rcmb.2007-0336RC Kato, 2012, Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88, J. Immunol., 188, 2014, 10.4049/jimmunol.1102405 Guang, 2010, Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen, J. Biol. Chem., 285, 20547, 10.1074/jbc.M110.121319 Farouk, 1991, The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen, Cancer, 68, 574, 10.1002/1097-0142(19910801)68:3<574::AID-CNCR2820680322>3.0.CO;2-B Steinberg, 1990, The clinical utility of the CA 19-9 tumor-associated antigen, Am. J. Gastroenterol., 85, 350 Winter, 2012, A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers, PLoS ONE, 7, e40157, 10.1371/journal.pone.0040157 Gold, 1994, Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin, Int. J. Cancer, 57, 204, 10.1002/ijc.2910570213 Curry, 2013, The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer, J. Surg. Oncol., 107, 713, 10.1002/jso.23316 Cheever, 2009, The prioritization of cancer antigens: a National Cancer Institute pilot project for the acceleration of translational research, Clin. Cancer Res., 15, 5323, 10.1158/1078-0432.CCR-09-0737 Kovjazin, 2011, ImMucin: a novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors, Vaccine, 29, 4676, 10.1016/j.vaccine.2011.04.103 Sangha, 2007, L-BLP25: a peptide vaccine strategy in non small cell lung cancer, Clin. Cancer Res., 13, s4652, 10.1158/1078-0432.CCR-07-0213 Butts, 2005, Randomized Phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer, J. Clin. Oncol., 23, 6674, 10.1200/JCO.2005.13.011 Kimura, 2013, MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study, Cancer Prev. Res. (Phila.), 6, 18, 10.1158/1940-6207.CAPR-12-0275 Takashi, 2013, MUC1 immunotherapy is here to stay, Expert Opin. Biol. Ther., 13, 35, 10.1517/14712598.2012.725719 Beatson, 2010, MUC1 immunotherapy, Immunotherapy, 2, 305, 10.2217/imt.10.17 Lakshminarayanan, 2012, Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine, Proc. Natl. Acad. Sci. U.S.A., 109, 261, 10.1073/pnas.1115166109 Mukherjee, 2009, Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition, J. Immunol., 182, 216, 10.4049/jimmunol.182.1.216 Yin, 2011, MUC1-C oncoprotein blocks terminal differentiation of chronic myelogenous leukemia cells by a ROS-mediated mechanism, Genes Cancer, 2, 56, 10.1177/1947601911405044 Akporiaye, 2007, Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas, Vaccine, 25, 6965, 10.1016/j.vaccine.2007.06.063 Schroeder, 2004, MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation, Oncogene, 23, 5739, 10.1038/sj.onc.1207713 Singh, 2010, EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer, Oncogene, 29, 4741, 10.1038/onc.2010.215 Stroopinsky, 2013, MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells, Cancer Res., 73, 5569, 10.1158/0008-5472.CAN-13-0677 Dean, 2005, Tumour stem cells and drug resistance, Nat. Rev. Cancer, 5, 275, 10.1038/nrc1590 Chandel, 2000, Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1α during hypoxia: a mechanism of O2 sensing, J. Biol. Chem., 275, 25130, 10.1074/jbc.M001914200 Semenza, 2003, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer, 3, 721, 10.1038/nrc1187 Fruehauf, 2007, Reactive oxygen species: a breath of life or death?, Clin. Cancer Res., 13, 789, 10.1158/1078-0432.CCR-06-2082 Pandey, 1995, Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein, Cancer Res., 55, 4000 Hikita, 2008, MUC1* mediates the growth of human pluripotent stem cells, PLoS ONE, 3, e3312, 10.1371/journal.pone.0003312 Guo, 2013, EGFR-ERK signaling pathway down-regulates miRNA-145 in lung cancer cells, Chin. J. Oncol., 35, 187 Smorodinsky, 1996, Detection of a secreted MUC1/SEC protein by MUC1 isoform specific monoclonal antibodies, Biochem. Biophys. Res. Commun., 228, 115, 10.1006/bbrc.1996.1625 Hey, 2003, Transmembrane and truncated (SEC) isoforms of MUC1 in the human endometrium and fallopian tube, Reprod. Biol. Endocrinol., 1, 2, 10.1186/1477-7827-1-2 Jonckheere, 2013, Membrane-bound mucin modular domains: from structure to function, Biochimie, 95, 1077, 10.1016/j.biochi.2012.11.005 Mohr, 2013, MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster, PLoS ONE, 8, e73306, 10.1371/journal.pone.0073306 Rajabi, 2013, MUC1-C oncoprotein activates ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition, Oncogene